Gender Dysphoria — What Neurobiology Actually Knows 🧠

In plain language: gender dysphoria is the clinical distress that can accompany the incongruence between experienced gender and sex assigned at birth. The incongruence is the phenomenon; the dysphoria is the suffering it can — not necessarily — produce. It is the biological mechanisms of this incongruence that science has been investigating.

The sexual development of the human brain does not happen at the same time as genital development. This is one of the most important and least discussed findings outside academia: genitalia and brain sexually differentiate in distinct temporal windows during gestation. The genitalia differentiate in the first weeks. The brain, especially hypothalamic regions linked to behavior and identity, differentiates later — under the influence of a second hormonal wave.^[5][6]

This means it is biologically possible — and documented in natural conditions — for an organism to have genitalia developed in one direction and brain organization developed in another. Not as error. As a consequence of two independent temporal windows responding to hormonal signals that can differ from each other.

The most robust evidence comes from women with Congenital Adrenal Hyperplasia (CAH). A study published in Brain Communications (October 2025) found that women with CAH — who have XX chromosomes, ovaries and uterus, but were exposed to excess androgens during gestation — showed brain characteristics significantly closer to the male pattern than control women, even in adulthood. The study was precise: “we support the hypothesis that prenatal androgen exposure has formative effects on the human brain that persist into adulthood.”^[7][8]

This finding matters because it controls for the exogenous hormone confound: these women did not undergo masculinizing hormone therapy — the exposure was prenatal, endogenous, involuntary. And the brain still organized differently.^[5]

If the prenatal window shows that hormones shape the brain, twin studies ask a different question: is there a heritable component to gender dysphoria? The answer science has given: yes, with important nuances.

Monozygotic (MZ) twins share 100% of DNA; dizygotic (DZ) twins share ~50%. If dysphoria has a genetic component, concordance should be higher in MZ than DZ. And that is exactly what the data shows: concordance in MZ twins ranges from 28.4% to 39.1%, versus 0% to 2.6% in DZ twins. A Nature study (2022) based on Swedish registry data found 37% concordance in different-sex twin pairs versus 0% in same-sex pairs.^[9][10]

A 2026 case report is particularly notable: monozygotic triplets, all with gender dysphoria, all who transitioned. Three genetically identical organisms, three convergent experiences.^[11]

What twin studies prove with rigor: there is a significant heritable component. What they don’t prove: that genetics is the sole factor. The 39% MZ concordance also means 61% of identical twins disagree — indicating that epigenetic, environmental, and developmental factors also participate. Genetics contributes. It doesn’t determine alone.

BSTc — the first finding, the most debated: In 1995, neuroscientist Dick Swaab published a landmark study: in post-mortem brains, the BSTc of trans women had volume equivalent to that of cis women — significantly smaller than cis men. The methodological limitation is real: six trans women’s brains, all post-HRT. The legitimate critique is that the study cannot separate whether BSTc size is a cause of dysphoria or a consequence of hormonal treatment. Direction of causation remains debated.^[6][12]

INAH-3 — the most robust hypothalamic finding: A 2026 integrative review states directly: “INAH-3 is confirmed as the most robust structure of sexual dimorphism in the human brain, with volume and neuron count significantly larger in cis men.” In trans women, “a complete structural reversal of INAH-3 was observed, resembling the female pattern, regardless of circulating hormones in adulthood.” That clause — “regardless of circulating hormones” — directly addresses the HRT confound.^[12][13][14]

Functional connectivity — the most recent advance: A 2025 study (Dosenbach Lab, Washington University) used machine learning on Adolescent Brain Cognitive Development data to compare resting-state functional connectivity with cortical thickness. Functional connectivity predicted sex/gender alignment with 85% accuracy, versus 76% for cortical thickness. Translation: how brain regions communicate carries more information about gender congruence than static anatomy.^{[15][16][17][18]}

A study in Frontiers in Neuroscience (2021) conducted genome-wide epigenomic analysis in people with gender incongruence before any hormonal treatment. It found DNA methylation patterns statistically different from controls — suggesting epigenetic differences exist independently of exogenous hormones and may originate in prenatal development.^[19][20]

Studies on gene variants in genes linked to brain sexual differentiation — androgen receptor (AR), CYP17A1, CYP19A1 (aromatase) — have shown mixed results: some groups found associations, others could not replicate. The honest conclusion: “epigenetics may be implicated in the basis of gender incongruence, but exact mechanisms still require additional research.”^[21][22]

Epigenetics best explains why identical twins can have different experiences: same DNA, expressed differently due to intrauterine environment signals — position, circulation, maternal hormones — that differ even between twins.

The public debate’s problem is treating all three as one thing — then using evidence about one as proof (or refutation) of the other two. The science documented in this text speaks primarily about the basis of dysphoria and incongruence — not about the legitimacy of any specific gender expression.

Science does not yet have a unified causal theory for gender dysphoria. The neurobiological findings are convergent — multiple lines of evidence pointing in the same direction — but no single structure or mechanism explains the phenomenon completely. The most robust current model (Gliske, 2019, eNeuro) focuses not on structure sizes but on neural network activity: three networks — of distress, social behavior, and body ownership — whose altered activity would produce both the suffering and the sense of incongruence.^[23]

Science does not know with certainty whether the observed brain differences are causes of dysphoria, consequences of living with it, or both simultaneously. The distinction matters scientifically — but doesn’t change the fact that the differences are real and measurable.

Science does not yet have definitive biological markers that enable diagnosis by examination. Gender dysphoria remains a clinical diagnosis, based on reported experience and observed distress. The neurobiological findings support understanding — they are not diagnostic tools.

There is a philosophical trap at the center of this discussion: that the legitimacy of gender dysphoria depends on biological proof. That if science doesn’t “prove” a substrate, the suffering stops being real. This trap works in both directions: deniers use lack of definitive evidence to say “no biological basis, therefore choice”; supporters sometimes overload available evidence to say “biology proves everything.” Both distort what science actually says.

What science actually says is simpler and more interesting: gender dysphoria has neurobiological substrate documented across multiple independent layers — prenatal exposure, twin studies, hypothalamic structures, functional connectivity, epigenetics. No single layer is conclusive proof. The convergence between them is legitimate scientific evidence that we are dealing with a phenomenon with real biological roots.

And at the same time: suffering does not need biological justification to deserve clinical attention. Tension headaches have no definitive neuroimaging marker. Migraines have no test that “proves” them. That doesn’t make those conditions less real, less treatable, or less worthy of medical care.